3M Integrated Cycler is a compact, portable testing platform that can provide results in as few as 60 minutes following sample extraction.
Simplexa tests employ real-time polymerase chain reaction (RT-PCR) to qualitatively and quantitatively detect viruses, bacteria and other agents.
The Simplexa C. difficile Universal Direct test is performed on liquid or unformed human stool samples and detects toxin producing strains of Clostridium difficile, including NAP1/B1/027.
Focus Diagnostics, a business of Quest Diagnostics, has launched the Simplexa molecular product line in 2009 with a focus on influenza and respiratory syncytial virus.
Since that time, the Simplexa product line has expanded to include Tests for detecting Flu A/B and Respiratory Syncytial virus, EBV, BK virus and Bordetella pertussis.
Focus Diagnostics will unveil the new test as well as the Simplexa Epstein Barr (EBV) and BK Virus tests, which were CE marked recently, during the European Congress of Clinical Microbiology and Infectious Disease Tradeshow, which begins on 7 May in Milan.
